Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review
- Supplementary File 1:
RAR-Document (RAR, 61 KiB)
Kosinska-Kaczynska, K.; Zgliczynska, M.; Kozlowski, S.; Wicherek, L. Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review. J. Clin. Med. 2020, 9, 183. https://doi.org/10.3390/jcm9010183
Kosinska-Kaczynska K, Zgliczynska M, Kozlowski S, Wicherek L. Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review. Journal of Clinical Medicine. 2020; 9(1):183. https://doi.org/10.3390/jcm9010183
Chicago/Turabian StyleKosinska-Kaczynska, Katarzyna, Magdalena Zgliczynska, Szymon Kozlowski, and Lukasz Wicherek. 2020. "Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review" Journal of Clinical Medicine 9, no. 1: 183. https://doi.org/10.3390/jcm9010183
